Pulmonary hypertension as a risk assessment factor for unfavorable outcome in patients with COVID-19
Aim. To determine the predictive role of estimated pulmonary artery systolic pressure (ePASP) in COVID-19 patients.Material and methods. A retrospective study of inpatients with documented COVID-19 infection was carried out. Maximal follow-up period was 63 days. The study included 108 patients (men,...
Main Authors: | E. Z. Golukhova, Inessa Viktorovna Slivneva, M. M. Rybka, M. L. Mamalyga, M. N. Alekhin, I. V. Klyuchnikov, D. E. Antonova, D. I. Marapov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2020-12-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4136 |
Similar Items
-
Transthoracic Echocardiography-Based Prediction Model of Adverse Event Risk in Patients with COVID-19
by: Elena Zelikovna Golukhova, et al.
Published: (2022-04-01) -
Infective endocarditis of a forgotten valve
by: Andreia Freitas, et al.
Published: (2023-01-01) -
Right ventricular free-wall longitudinal speckle tracking strain as a prognostic criterion of adverse outcomes in patients with pulmonary hypertension: a systematic review and meta-analysis
by: E. Z. Golukhova, et al.
Published: (2021-05-01) -
Left Ventricular Longitudinal Systolic Function in Septic Shock Patients with Normal Ejection Fraction: A Case-control Study
by: Hong-Min Zhang, et al.
Published: (2017-01-01) -
Prevalence of pulmonary hypertension in chronic simple silicosis patients and its correlation with smoking history, occupation type, age and duration of silica exposure
by: Jyoti Kumari, et al.
Published: (2023-11-01)